PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 68 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $16,000 | -11.1% | 53,110 | +28.8% | 0.00% | – |
| Q3 2016 | $18,000 | +28.6% | 41,230 | +5.3% | 0.00% | – |
| Q2 2016 | $14,000 | -99.4% | 39,139 | -99.3% | 0.00% | -100.0% |
| Q1 2016 | $2,464,000 | -60.1% | 5,860,146 | +11.0% | 0.00% | 0.0% |
| Q4 2015 | $6,177,000 | +18.4% | 5,279,818 | +3.2% | 0.00% | 0.0% |
| Q3 2015 | $5,217,000 | -19.7% | 5,114,747 | +3.2% | 0.00% | -50.0% |
| Q2 2015 | $6,494,000 | -4.9% | 4,957,451 | -2.0% | 0.00% | 0.0% |
| Q1 2015 | $6,826,000 | -0.6% | 5,056,557 | +2.4% | 0.00% | 0.0% |
| Q4 2014 | $6,864,000 | +18.4% | 4,938,152 | +15.8% | 0.00% | 0.0% |
| Q3 2014 | $5,798,000 | -29.9% | 4,263,597 | -3.0% | 0.00% | 0.0% |
| Q2 2014 | $8,266,000 | -10.8% | 4,396,565 | -9.8% | 0.00% | -33.3% |
| Q1 2014 | $9,262,000 | +54.8% | 4,874,832 | +13.3% | 0.00% | +50.0% |
| Q4 2013 | $5,982,000 | -0.1% | 4,303,670 | +0.7% | 0.00% | 0.0% |
| Q3 2013 | $5,985,000 | +35.7% | 4,275,308 | +25.1% | 0.00% | 0.0% |
| Q2 2013 | $4,409,000 | – | 3,417,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 245,000 | $287,000 | 0.41% |
| Iguana Healthcare Management, LLC | 500,000 | $585,000 | 0.19% |
| Sterling Global Strategies LLC | 10,000 | $12,000 | 0.19% |
| Delaney Dennis R | 60,000 | $70,000 | 0.16% |
| Freedom Investment Management, Inc. | 816,347 | $955,000 | 0.07% |
| BAXTER BROS INC | 135,506 | $159,000 | 0.06% |
| First Heartland Consultants, Inc. | 86,204 | $101,000 | 0.04% |
| TWO SIGMA SECURITIES, LLC | 16,191 | $19,000 | 0.02% |
| CORRADO ADVISORS, LLC | 15,000 | $18,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 368,830 | $432,000 | 0.01% |